Dignify Therapeutics
Manufacturing · North Carolina, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2 Davis Dr, Durham, North Carolina, 2770...Phone Number
(919) 371-8138Website
www.dignifytherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Dignify Therapeutics
Dignify Therapeutics specializes in developing on-demand drugs that help restore control of bowel and bladder function for individuals in need. Their innovative approach allows users to trigger the emptying of these bodily functions at their convenience. The company aims to improve the quality of life for patients facing challenges related to bowel and bladder control. Their target clients include individuals requiring assistance with these functions, enhancing their autonomy and comfort.Explore more
Dignify Therapeutics Org Chart
EV
Chief Medical Officer
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Dignify Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Dignify Therapeutics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Dignify Therapeutics
Check out if Dignify Therapeutics is spiking on competitors!
Funding: Get notified immidiatlly once Dignify Therapeutics has new funding data
Dignify Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Dignify Therapeutics launches new products
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Dignify Therapeutics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Dignify Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Dignify Therapeutics as Masked Content
Find 2 more new buyers
Compare Similar Companies to Dignify Therapeutics
Compare insights from companies similar to Dignify Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Dignify Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Dignify Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Dignify Therapeutics.
Dignify Therapeutics financials insights
Gather financial insights about Dignify Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Private Equity
$3.4M
2015
Debt
$250K
Private Equity
$3.1M
2017
Private Equity
$4.1M
2020
Debt
$150K
Dignify Therapeutics Tech Stack
A closer look at the technologies used by Dignify Therapeutics
Most Recent Scoops
Funding
Project
Spending/Investment, Funding
New Hire
Executive Move
Executive Moves, New Hire
Funding
Project
Spending/Investment, Funding
New Hire
Executive Move
Executive Moves, New Hire
Funding
Project
Laboratory Operations, Clinical Operations, Operations
Dignify Therapeutics News & Media
Dignify Therapeutics Highlights Clinical Development Plans at BIO CEO & Investor Conference
RESEARCH TRIANGLE PARK, N.C., Feb. 14, 2025 /PRNewswire/ -- Dignify Therapeutics, a biotechnology company dedicated to restoring voluntary bowel and bladder function in patients with neurological conditions, presented its clinical development plans for its lead assets, DTI-117 and...Dignify Therapeutics Selected as a Praxis SCI Accelerate Company
RESEARCH TRIANGLE PARK, N.C, Oct. 22, 2024 /PRNewswire/ -- Dignify Therapeutics (Dignify), a leading developer of therapies for bladder and bowel dysfunction, has been selected as a participating company in the Praxis Spinal Cord Injury (SCI) Accelerate Program. SCI Accelerate is a...Dignify to highlight recent accomplishments at the 2024 BIO Investor Forum
RESEARCH TRIANGLE PARK, N.C., Oct. 15, 2024 /PRNewswire/ -- Dignify Therapeutics (Dignify), a leading developer of therapies for bladder and bowel dysfunction, announced that Tony DiTonno, CEO and Executive Chairman, will provide a status update on the company's two lead drug development...Dignify Therapeutics welcomes leading healthcare entrepreneurs Howard Palefsky and Neil Kurtz, MD to its Board of Directors
RESEARCH TRIANGLE PARK, N.C., Oct. 9, 2024 /PRNewswire/ -- Dignify Therapeutics (Dignify), a leading developer of therapies for bladder and bowel dysfunction, announced that Howard Palefsky and Dr. Neil Kurtz have joined Dignify's Board of Directors. Mr. Palefsky has a broad range of...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Dignify Therapeutics
Sign Up For FreeTo access detailed company insights
Dignify Therapeutics specializes in developing on-demand drugs that help restore control of bowel and bladder function for individuals in need. Their innovative approach allows users to trigger the emptying of these bodily functions at their convenience. The company aims to improve the quality of life for patients facing challenges related to bowel... Read More
